Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210
2019 ◽
Vol 35
(8)
◽
pp. 691-697
◽
Keyword(s):
2012 ◽
Vol 6
(3)
◽
pp. 311-320
◽
2000 ◽
Vol 6
(5)
◽
pp. 415-422
◽
Keyword(s):
2002 ◽
Vol 186
(2)
◽
pp. 198-204
◽
2000 ◽
Vol 181
(4)
◽
pp. 1486-1490
◽